Navigation Links
Helix BioPharma Reports on 2008 Annual General Meeting and Provides Corporate Update
Date:12/16/2008

AURORA, Ontario, Dec. 16 /PRNewswire/ -- Helix BioPharma Corp. (TSX, FSE: HBP) reports that at its Annual General Meeting held today, shareholders overwhelmingly approved all of management's proposals.

Annual General Meeting Results

All seven Board members were re-elected as directors, with the Board continuing to be constituted of:

    Donald H. Segal        Chairman of the Board and Chief Executive Officer
    Kenneth A. Cawkell     Director and Corporate Secretary
    John Docherty          Director and President
    Thomas Hodgson         Director
    Jack Kay               Director
    Gordon M. Lickrish     Director
    Slawomir Majewski      Director

KPMG LLP was re-appointed as the Company's auditor.

The shareholders also approved the Company's 2008 new Stock Option Plan. Details regarding the new plan are contained in the Company's Information Circular dated Oct. 28, 2008, filed on SEDAR at www.sedar.com.

Research & Development Update

The Company is continuing its efforts toward milestone investigational new drug application (IND) filings in the United States for L-DOS47 and Topical Interferon Alpha-2b, in its cervical dysplasia indication, by the end of its 2009 fiscal year ending July 31, 2009.

L-DOS47

Helix intends to conduct a pre-IND meeting with the FDA to confirm its North American Phase I program plans for L-DOS47. The Company expects the pre-IND meeting to occur in the beginning of the 2009 calendar year. Pending the positive outcome of the pre-IND meeting and timely success of the ongoing and remaining pre-clinical and manufacturing preparatory initiatives, the Phase I IND filing for this program is anticipated to occur sometime before the
'/>"/>

SOURCE Helix BioPharma Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. CSL Behrings Helixate(R) FS Now Available in 2000 IU Vial Size to Improve Patient Convenience, Encourage Compliance
2. PDL BioPharma to Actively Seek Sale of Entire Company or Its Key Assets
3. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
4. Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting
5. Nabi Biopharmaceuticals Completes Sale of Nabi Biologics to Biotest AG
6. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia
7. Aladdin eToken First Strong Authentication Device to Achieve Certification from the SAFE-BioPharma Association
8. XTL Biopharmaceuticals Announces Financial Results for the Year Ended December 31, 2007
9. ARCA Discovery Changes Name to ARCA biopharma to Reflect Focus on Drug Commercialization
10. CeNeRx BioPharma Appoints Mahnaz Asgharnejad as Vice President of Clinical Development
11. Immunosyn Announces Proposed Agreements for Distribution of the Biopharmaceutical SF-1019 in Utah
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... TX (PRWEB) , ... July 03, 2015 , ... ... the United States, named Mariah N. Manzanares, MD as the new Medical Director of ... new facility medical director of our Frisco facility,” said Dr. James M. Muzzarelli, Executive ...
(Date:7/3/2015)... , ... July 03, 2015 , ... The Celebrity Dresses ... cocktail dresses similar to those of celebrities will have the opportunity to get 10% ... checkout. This ensures that people do not have to use coupon codes or remember ...
(Date:7/2/2015)... ... July 02, 2015 , ... Following the recent report by ... of obese Americans outnumber merely overweight Americans, Samir Becic emphatically declared a war on ... American society right now," Becic said. "We must understand the magnitude of this discovery. ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... With summer in full swing, Americans are ... is one of the top spots for fishing in the world, and it’s easy to ... of Ontario, Canada has great fish. , Recreational fishing is a huge industry, and ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... of the SIGVARIS PERFORMANCE SOCKS. Since the socks were first introduced, they have ... Their significant popularity has inspired four new, fun shades including: blue, lime, pink ...
Breaking Medicine News(10 mins):Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3Health News:Celebrity Fashion Summer Party Dresses on sale at TheCelebrityDresses.com 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 4Health News:SIGVARIS is Sporting Four Brand New Colors in the Popular PERFORMANCE SOCK Product Line 2
... study had identified a mutant form of the enzyme ... less or no hangover from consuming alcohol. ,Researchers ... the toxicity of acetaldehyde leads to hangovers in individuals ... dehydrogenase (ALDH) is the most important enzyme involved in ...
... “black box warning” to three asthma drugs//, Foradil, ... the manufacturers that the drug should carry clearly ... ,Adavir and Serevent are manufactured by ... the drug Foradil which contains a different long-acting ...
... conducted by University of California-San Francisco has published that ... cardiovascular system by increasing heart beat rate and ... and potassium homeostasis. ,The study spearheaded by Dr. ... took the experimental group of 16 healthy adults. Two ...
... in emergencies may be asking patients to go for more ... in a lawsuit for malpractice. ,In a study done ... of being sued for malpractice may be the guiding point ... who are more afraid of a law suit than their ...
... believed it, some of us believe it but science is ... link between faith, health and healing. ,Some scientists ... prayer, worship, and service to others, influence our health. ... get well” but a “holistic approach to wellness”, which unites ...
... shown that daily oral doses of Lorenzos oil can prevent ... X-linked adrenoleukodystrophy (X-ALD). ,Researchers from Kennedy Krieger Institute ... prevented the spread of the disease X-ALD in boys aged ... The children had the their daily doses of the oil, ...
Cached Medicine News:Health News:FDA gives “black box warning” against three asthma dru 2Health News:Link between Faith, Health and Healing 2Health News:Link between Faith, Health and Healing 3
(Date:7/2/2015)... England , July 2, 2015 ... known as ,Friendly Aedes aegypti , , ... Juazeiro, Brazil by 95%, well ...      (Logo: http://photos.prnewswire.com/prnh/20150630/227348LOGO) , The journal ... a trial of Oxitec,s genetically engineered mosquitoes. The results ...
(Date:7/2/2015)... DALLAS , July 2, 2015 ... Market by Technology (Deep Brain Stimulation, Spinal Cord Stimulation, Transcranial ... Trends & Global Forecast to 2020", published by MarketsandMarkets, the ... and is projected to reach $6.20 Billion by 2020, at ... Browse 8 4 market ...
(Date:7/2/2015)... Research and Markets( http://www.researchandmarkets.com/research/nlfg34/cancer ) has announced the addition ... Application - Forecast to 2020" report to their offering. ... Billion in 2020 from an estimated $7.1 Billion in 2015, growing ... by North America , followed by ... the World (RoW). The cancer diagnostics market in Asia ...
Breaking Medicine Technology:Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 2Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 3Neuromodulation Market Worth $6.20 Billion by 2020 2Neuromodulation Market Worth $6.20 Billion by 2020 3Neuromodulation Market Worth $6.20 Billion by 2020 4Global Cancer Diagnostics Market Report 2015 - Technology, Imaging and by Applications Forecasts to 2020 for the $13 Billion Industry 2
... BEIJING, May 17, 2012 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical ... or the "Company"), an emerging leader in the development, ... medical products, today announced that the Company will present ... be held at the Shanghai Purple Mountain Hotel in ...
... Simbionix USA Corporation, the world,s leading provider ... proud to announce the release two new platform ... Express simulator and the enhanced hardware for ... (Logo: http://photos.prnewswire.com/prnh/20120502/529202-a) ,     (Photo: ...
Cached Medicine Technology:Dehaier Medical to Present at the CFA 2012 Cross-Continental Summit on Investment in Shanghai 2Simbionix Releases Two New Platforms at the Upcoming DDW and AUA Events 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: